Synthesis of azole derivatives from 3-phenylaminopropanohydrazide and evaluation of their antimicrobial efficacy

Article abstract of DOI:10.3987/COM-08-11478

Novel pyrrole and pyrazole derivatives containing phenylaminopropanoyl moiety were synthesized from 3-phenylaminopropanohydrazide through its condensation with diketones. The intramolecular cyclization reaction of disubstituted semicarbazides and thiosemi

Full text of DOI:10.3987/COM-08-11478

HETEROCYCLES, Vol. 78, No. 1, 2009
59
HETEROCYCLES, Vol. 78, No. 1, 2009, pp. 59 - 70. © The Japan Institute of Heterocyclic Chemistry
Received, 3rd July, 2008, Accepted, 22nd August, 2008, Published online, 25th August, 2008.
DOI: 10.3987/COM-08-11478
SYNTHESIS OF AZOLE DERIVATIVES FROM
3-PHENYLAMINOPROPANOHYDRAZIDE AND EVALUATION OF
THEIR ANTIMICROBIAL EFFICACY
Ingrida Tumosienė,1 Kristina Kantminienė,2 Alvydas Pavilonis,3 Žaneta
Maželienė,3 and Zigmuntas J. Beresnevičius1*
1Department of Organic Chemistry, Kaunas University of Technology, Radvilenu
19, LT-50254 Kaunas, Lithuania (E-mail: Zigmuntas.Beresnevicius@ktu.lt)
2Department of General Chemistry, Kaunas University of Technology, Radvilenu
19, LT-50254 Kaunas, Lithuania
3Department of Microbiology, Kaunas University of Medicine, Eiveniu 4,
LT-50009 Kaunas, Lithuania
Abstract – Novel pyrrole and pyrazole derivatives containing phenylamino-
propanoyl moiety were synthesized from 3-phenylaminopropanohydrazide
through its condensation with diketones. The intramolecular cyclization reaction
of disubstituted semicarbazides and thiosemicarbazides was used to prepare new
1,3,4-thiadiazole, 1,3,4-oxadiazole and 1,2,4-triazole compounds. Some of the
synthesized compounds were evaluated for in vitro antimicrobial activity.
INTRODUCTION
Chemical and biological properties of hydrazides, semicarbazides, and the products of their
heterocyclization have been widely studied. In particular, some semicarbazides exhibit convincing
antimicrobial activity.1,2 1,2,4-triazoles and 1,3,4-oxadiazoles are known for their anti-inflammatory,3 and
antibacterial effect.4,5 Triazole system is a structural element of many drugs that have antimycotic activity
such as fluconazol, itraconazol, voriconazol.6 N-substituted 3-aminopropanoic acids and their salts are
known to elicit a broad spectrum of biological activities.7-10 As a part of our study aimed at investigating
transformations of N-substituted β-amino acid derivatives, in this work we report the synthesis of the
five-membered heterocyclic compounds from 3-(phenylamino)pronanohydrazide through direct
transformations or via intermediate semicarbazides.

60
HETEROCYCLES, Vol. 78, No. 1, 2009
RESULTS AND DISCUSSION
3-(Phenylamino)propanohydrazide10 was synthesized from N-phenyl-β-alanine (1) and hydrazine in
refluxing toluene (Scheme 1). Condensation of hydrazide 2 with alkanediones was carried out in acidic
medium. Heating of 2 with 2,4-pentanedione in the presence of hydrochloric acid gave pyrazole
derivative 3, whereas when 2 was heated with 2,5-hexanedione in the presence of a catalytic amount of
acetic acid N-(2,5-dimethyl-1H-pyrrol-1-yl)-3-(phenylamino)propanamide (4) was obtained since only
amino group of hydrazide moiety participated in the cyclization process. Formation of the cycles was
supported by NMR spectra. In the 1H NMR spectrum of 3 singlets of methyl group of pyrazole moiety are
observed at 2.20 and 2.49 ppm. Singlets of two equivalent methyl groups at 1.96 ppm and two CH groups
at 5.62 ppm confirmed the structure of pyrrole 4.
13
12
11
14
15
HN
16
H
2
5
8
H
N
10
N
9
3
NH2NH2
PhNCX
1
6
N
X
7
H
4
O
5
6
X=O
X=S
HN
HN
O
O
1
2
NHNH2
PhNCX
OH
X
N
17
CH3COCH2COCH3
CH3CO(CH2)2COCH3
19
22
HN
O
18
20
21
NH
23
Me
HN
3
5
2
10
N
H
2
N
H
4
NH
8
X
1
11
N
N
9
3
4
1
7
8
6
7
12
H
9
14
N
Me
Me
O
6
O
N
5
10
11
7 X=O
Me
15
13
3
12
4
8
X=S
Scheme 1
Depending on the amount of the used isocyanates, semicarbazides 5 and 6 or their N-phenylcarbamoyl
derivatives 7 and 8 were obtained in the reaction of propanohydrazide 2 with phenyl isocyanate or phenyl
isothiocyanate. Strong absorption band of carbonyl group at 1678 cm-1 and adsorption band of the C=S
group at 1175 cm-1 supported the structure of 3-(phenylamino)-N-[(phenylthiocarbamoyl)amino]pro-
panamide (6). In the IR spectrum of 8 absorption band attributed to CO group was observed at 1704 cm-1,
and two C=S group bands were identified at 1159 and 1218 cm-1.
The reaction of cyclization of acyl semicarbazide derivatives depends on the pH of the medium and

HETEROCYCLES, Vol. 78, No. 1, 2009
61
substituents present in semicarbazide derivatives. Cyclization of these compounds in an alkaline medium
results in 1,2,4-triazole system, whereas reaction in acidic medium affords compounds with
1,3,4-oxadiazole ring.4,6,11-13
7
5
a) POCl3
or
b) HCl
1) KOH
2) HCl
1) KOH
2) AcOH
H
N
N
N
O
H
O
H
N
O
O
N
N
N
O
N
N
N
Ac2O
N
H
N
HN
Me
12
9
13
Scheme 2
Refluxing of phenylcarbamoylaminopropanamide 5 in aqueous 20 % KOH with the subsequent
acidification of the reaction mixture with hydrochloric acid afforded 4-phenyl-3-[2-(phenylamino)ethyl]-
1H-1,2,4-triazol-5(4H)-one (9) in 60-70 % yield (Scheme 2). The same method applied to 7 resulted in
the formation of the same triazole 9 because hydrolysis of the phenylcarbamoyl group took place along
with the cyclization process. The IR spectrum of 9 showed absorption bands characteristic to
1,2,4-triazolone ring vibrations at 1519, 1367, and 1191 cm-1, and absorption band attributed to one
carbonyl group at 1665 cm-1.
1H NMR spectra of 9 and 10 reveal the deshielding effect of triazole ring on the adjacent methylene group.
Its triplet was shifted down-field in comparison with the proton signals of methylene group in
propanohydrazide moiety and was observed at 2.63 ppm and 2.57 ppm for 9 and 10, respectively.
Semicarbazide 5 and its phenylcarbamoyl derivative 7 underwent cyclization to oxadiazole derivatives 11
and 12 when heated under reflux with HCl or POCl3 (Schemes 2 and 3). The same method applied to
thiosemicarbazide 6 gave 14. Cyclization of 3-(phenylamino)-N-[(phenylcarbamoyl)amino]propanamide
(5) was more rapid in hydrochloric acid than in phosphoryl chloride. The yield of 11 after heating under
reflux in dilute hydrochloric acid (1:1) for 1 h was 64 %, whereas such yield was not achieved even after
36 h of reflux in POCl3. N-Phenyl-5-[2-(phenylamino)ethyl]-1,3,4-thiadiazol-2-amine (14) was
synthesized in good yield by keeping thiosemicarbazide 6 in concentrated sulfuric acid at room
temperature. The same thiadiazole 14 was also prepared from propanamide 5 by heating under reflux in
xylene with P2S5.

62
HETEROCYCLES, Vol. 78, No. 1, 2009
H
N
N
N
O
PhNCO
a) POCl3 or b) HCl
12
5
N
H
11
P2S5
H
N
N
N
S
a) HCl, b) H2SO4 or c) POCl3
N
6and
6
8
H
14
1) KOH
2) HCl
H
N
S
H
S
N
N
N
N
N
Ac2O
N
N
H
Me
17
18
O
10
15
Scheme 3
Compound 12 was synthesized by treating oxadiazole 11 with phenyl isocyanate. Heating under reflux of
triazoles 9 and 10 with acetic anhydride afforded N-acylated compounds 13 and 15.
1
Proton signal of NH group was absent in the H NMR spectra of acylated derivatives 13 and 15 in
comparison with the respective spectra of 9 and 10, but singlet attributed to three protons of acetyl group
was observed at 1.91, 1.66 ppm.
BIOLOGIGAL ACTIVITY
The potential antimicrobial activity of compounds 4-12 and 14 towards eight bacterial strains and
antifungal activity towards Candida albicans were investigated.
The experiments have revealed that the presence of oxadiazole and thiadiazole rings stipulates
antimicrobial activity of the investigated compounds. Pyrrole 4, semicarbazides 5–8, and triazoles 9 and
10 had no inhibitory activity on the tested microorganism strains. Oxadiazole 11 exhibited the widest
range of activity (Table 1). It completely inhibited growth of Staphylococcus aureus at 100 μg/mL,
growth of Enterococcus faecalis at 250 μg/mL, and growth of Bacillus subtilis and Bacillus cerius at 150
μg/mL. MIC of oxadiazole 12 towards Staphylococcus aureus, Bacillus subtilis, and Bacillus cerius were
150 μg/mL, 200 μg/mL, and 250 μg/mL, respectively. Thiadiazole 14 exhibited activity towards Candida
albicans (300 μg/mL), Bacillus subtilis (450 μg/mL) and Bacillus cerius (450 μg/mL).

HETEROCYCLES, Vol. 78, No. 1, 2009
63
Table 1. Antimicrobial activity of compounds 11, 12 and 14
Compound 11
500
450
400
350
300
250
200
150
100
50
+*
+
+
+
+
+
+
+
+
–
+
+
+
+
+
+
–
–
–
–
–
–
–**
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
+
+
+
+
+
+
+
+
–
–
–
–
+
+
+
+
+
+
+
+
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
25
1
–
–
Compound 12
500
450
400
350
300
250
200
150
100
50
+
+
+
+
+
+
+
+
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
+
+
+
+
+
+
+
–
–
–
–
–
+
+
+
+
+
+
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
25
1
Compound 14
500
450
400
350
300
250
200
150
100
50
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
+
+
–
–
–
–
–
–
–
–
–
–
+
–
–
–
–
–
–
–
–
–
–
–
+
+
+
+
+
–
–
–
–
–
–
–
25
1
* + – the compound exhibits antimicrobial activity (growth of the microbial strain is inhibited),
** – – the compound does not exhibit antimicrobial activity

64
HETEROCYCLES, Vol. 78, No. 1, 2009
CONCLUSIONS
Reactions of 3-(phenylamino)propanohydrazide with aliphatic 2,4-pentanedione and 2,5-hexanedione
gave dimethylpyrazole and dimethylpyrrole derivatives. Mono- or diphenylcarbamoyl
3-phenylaminopropanamides were obtained by its reaction with isocyanates. The obtained compounds
underwent cyclization into oxadiazole, thiazole, and triazole derivatives. The synthesized compounds
containing oxadiazole or thiadiazole moieties exhibit antimicrobial activity.
EXPERIMENTAL
Melting points were determined on a Gallenkamp melting point apparatus and are uncorrected. NMR
spectra were recorded on a Varian Unity Inova (300 MHz) spectrometer using DMSO-d6 as a solvent.
1
Chemical shifts (δ) are reported in parts per million (ppm) calibrated from TMS (0 ppm) for H NMR,
and DMSO-d6 (39.5 ppm) for 13C NMR. The IR spectra were measured as potassium bromide pellets
using a Perkin-Elmer 1600 series FT-IR spectrometer. All chemicals were obtained from Fluka Chemie
AG Buchs (Switzerland). Flash column chromatography was carried out with silica gel 60 (Fluka Chemie
AG Buchs (Switzerland)).
3-(Phenylamino)propanohydrazide (2). N-Phenyl-β–alanine (1) (23.7 g, 0.1 mol) and hydrazine hydrate
(10 g, 0.2 mol) were stirred under reflux in toluene (500 mL) for 4 h. The solvent was removed on a
rotary evaporator, and the product was crystallized from 2-propanol. The crystals were filtered, washed
with Et2O, and recrystallized from 2-propanol. Yield 16.5 g (64.2 %), mp 93–94 ˚C.14 1H NMR (300
MHz, DMSO-d6): δ 2.30 (t, 2H, J = 6.75 Hz; CH2CO), 3.23 (t, 2H, J = 6.75 Hz, CH2NH), 4.22 (s, 2H,
NH2), 5.50 (s, 1H, NH), 6.57 (t, 1H, J = 7.5 Hz, Har-4), 6.51 (d, 2H, J = 8.1 Hz, Har-2,6), 7.07 (t, 2H, J = 8.1
Hz, Har-3,5), 9.05 (s, 1H, NHNH2). 13C NMR (75.4 MHz, DMSO-d6): δ 33.97 (CH2CO), 46. 31 (CH2NH),
106.14 (C-2); 113.85 (C-4), 131.34 (C-3), 146.09 (C-1), 173.43 (CO). MS (ESI, 20 V): m/z 180 [M+H]+
(100 %). Anal. Calcd for C9H13N3O: C, 60.32; H, 7.31; N, 23.45. Found: C, 60.41; H, 7.29; N, 23.21.
1-(3,5-Dimethyl-1H-pyrazol-1-yl)-3-(phenylamino)propan-1-one (3). A mixture of 2 (4.48 g, 25
mmol), 2,4-pentanedione (2 mL, 2.5 g, 25 mmol) and 2M HCl (1 mL) was refluxed in MeOH (50 mL) for
12 h. The liquid fractions were distilled on a rotary evaporator, and the oily residue was crystallized from
Et2O. The product was purified by flash column chromatography (acetone:hexane 1:1). Yield 4.2 g (70
%), mp 39–40 ºC. 1H NMR (300 MHz, DMSO-d6): δ 2.20, 2.49 (2s, 6H, 2 CH3), 3.33 (t, 2H, J = 7.2 Hz,
COCH2), 3.40 (t, 2H, J = 7.2 Hz, NCH2), 6.20 (s, 1H, CH=). 6.53 (t, 1H, J = 7.2 Hz, Har-4). 6.63 (d, 2H, J
= 8.1 Hz, Har-2,6). 7.10 (t, 2H, J = 8.1 Hz; Har-3,5). 13C NMR (75.4 MHz, DMSO-d6): δ 171.92 (C-9),
151.26 (C-10), 148.38 (C-1), 143.12 (C-11), 128.84 (C-3, 5), 115.70 (C-4), 111.97 (C-12), 111.06 (C-2,
6), 38.10 (C-7), 34.72 (C-8), 14.03 (C-14), 13.38 (C-13). IR (KBr), ν/cm-1: 1670 (CO). MS (ESI, 20V):

HETEROCYCLES, Vol. 78, No. 1, 2009
65
m/z 244 [M+H]+ (40%). Anal. Calcd for C14H17N3O: C, 69.11; H, 7.04; N, 17.27. Found: C, 68.93; H,
7.20; N, 17.08.
N-(2,5-Dimethyl-1H-pyrrol-1-yl)-3-(phenylamino)propanamide (4). A mixture of 2 (0.54 g, 3 mmol),
2-propanol (75 mL), 2,5-hexanedione (0.69 g, 6 mmol), and acetic acid (1.5 mL) was refluxed for 20 h.
Then cold water (25 mL) was added. The crystals were filtered and recrystallized from EtOH. Yield 0.55
g (71 %), mp. 134–135 ºC. 1H NMR (300 MHz, DMSO-d6): δ 1.96 (s, 6H, 2 CH3), 2.55 (t, 2H, J = 6.9 Hz,
COCH2), 3.36 (t, 2H, J = 6.9 Hz, NHCH2), 5.62 (s, 2H, 2 CH), 5.65 (s, 1H, NH), 6.55 (t, 1H, J = 7.2 Hz,
Har-4), 6.62 (d, 2H, J = 7.2 Hz, Har-2,6), 7.09 (t, 2H, J = 7.2 Hz, Har-3,5), 10.61 (s, 1H, NH). 13C NMR (75.4
MHz, DMSO-d6): δ 170.28 (C-9), 148.50 (C-1), 128.89 (C-3, 5), 126.67 (C-10, 13), 115.77 (C-4), 102.79
(C-11, 12), 112.03 (C-2, 6), 38.38 (C-7), 33.14 (C-8), 10.89 ((С-14, 15). IR (KBr), ν/cm-1: 3368 (NH),
1668 (C=O). MS (ESI, 20V): m/z 258 [M+H]+ (70%). Anal. Calcd for C15H19N3O: C, 70.01; H, 7.44; N,
16.33. Found: C, 69.95; H, 7.9; N, 15.98.
3-(Phenylamino)-N-[(phenylcarbamoyl)amino]propanamide (5). To a solution of 2 (4.48 g, 25 mmol)
in methanol (50 mL) phenyl isocyanate (2.98 g, 2.71 mL, 25 mmol) was added dropwise. The reaction
mixture was refluxed for 1 h, and cooled down. The crystals were filtered, washed with MeOH, and
recrystallized from MeOH. Yield 6.0 g (80 %), mp 133–134 ºC. 1H NMR (300 MHz, DMSO-d6): δ 2.46
(t, 2H, J = 7.2 Hz, CH2CO), 3.30 (t, 2H, J = 7.2 Hz CH2N), 6.55 (t, 1H, J = 7.2 Hz, Har-4), 6.96 (d, 2H, J =
8.5 Hz, Har-2,6), 7.09 (t, 2H, J = 8.5 Hz, Har-3,5), 7.23–7.47 (m, 5H, Har’), 8.06 (s, 1H, NHNHCO), 8.72 (s,
13
1H, NHNHCO), 9.76 (s, 2H, NHAr). C NMR (75.4 MHz, DMSO-d6): δ 170.84 (C-9), 155.35 (C-1),
148.50 (C-10), 139.51 (C-11), 128.88 (C-3, 5), 128.58 (C-13, 15), 121.85 (C-14), 118.43 (C-4), 115.83
(C-12, 16),112.09 (C-2, 6), 43.02 (C-7), 33.17 (C-8). IR (KBr), ν/cm-1: 3375, 3344, 3206 (NH); 1638
(CO). MS (ESI, 20 V): m/z 299 [M+H]+ (85 %). Anal. Calcd for C16H18N4O2: C, 64.41; H, 6.08; N, 18.78.
Found: C, 64.04; H, 6.03; N, 18.30.
3-(Phenylamino)-N-[(phenylthiocarbamoyl)amino]propanamide (6). To a solution of 2 (4.48 g, 25
mmol) in MeOH (50 mL) phenyl isothiocyanate (3.38 g, 2.99 mL, 25 mmol) was added dropwise. The
reaction mixture was refluxed for 5 min. The crystals were filtered, washed with Et2O, and recrystallized
o
1
from DMF – water mixture. Yield 5.97 g (65 %), mp 175–176 C. H NMR (300 MHz, DMSO-d6): δ
2.48 (t, 2H, J = 7.2 Hz, CH2CO), 3.29 (q, 2H, J = 7.2 Hz, CH2NH), 5.56 (s, 1H, NHAr), 6.51 (t, 1H, J =
7.2 Hz, Har-4), 6.57 (d, 2H, J = 8.5 Hz, Har-2,6), 7.08 (t, 2H, J = 7.2 Hz, Har-3,5), 7.16 (t, 1H, J = 7.2 Hz;
Har’-4), 7.33 (t, 2H, J = 7.2 Hz, Har’-3,5), 7.43 (d, 2H, J=7.2 Hz, Har’-2,6), 9.58 (s, 2H, NHNHCS), 10.00 (s,
1H, NHAr’). 13C NMR (75.4 MHz, DMSO-d6): δ 175.17 (C-10), 170.72 (C-9), 148.48 (C-1), 138.99
(C-11), 128.85 (C-3, 5), 127.99 (C-13, 15), 125.69 (C-14), 125.06 (C-4), 115.81 (C-12, 16), 112.06 (C-2,
6), 43.68 (C-7), 33.19 (C-8). IR (KBr), ν/cm-1: 3362, 3266, 3137 (NH), 1678 (CO), 1175 (CS). MS (ESI,
20V): 315 [M+H]+ (80%). Anal. Calcd for C16H18N4OS: C, 61.12; H, 5.77; N, 17.82. Found: C, 61.02; H,

66
HETEROCYCLES, Vol. 78, No. 1, 2009
5.69; N, 18.08.
3-[Phenyl(phenylcarbamoyl)amino]-N-[(phenylcarbamoyl)amino]propanamide (7). To a solution of
2 (4.48 g, 25 mmol) in MeOH (50 mL) phenyl isocyanate (8.93 g, 8.11 mL, 75 mmol) was added
dropwise. The reaction mixture was refluxed for 5 min. The crystals were filtered, washed with Et2O, and
recrystallized from MeOH. Yield 8.84 g (85 %), mp 121–122 oC. 1H NMR (300 MHz, DMSO-d6): δ 2.47
(t, 2H, J = 7.2 Hz, CH2CO), 3.94 (t, 2H, J = 7.2 Hz, CH2N), 6.92–7.50 (m, 15H, HAr,Ar’,Ar’’), 8.06, 8.03 (2s,
13
2H, NHNHCO), 8.72 (s, 1H, NHAr”), 9.80 (s, 1H, NHAr’). C NMR (75.4 MHz, DMSO-d6): δ 170.49
(C-9), 155.21 (C-17), 154.45 (C-10), 141.87 (C-1), 139.83 (C-11), 139.48 (C-18), 129.49 (C-3, 5), 128.51
(C-2, 6), 128.17 (C-20, 22), 127.76 (C-4), 126.63 (C-13, 15), 121.95 (C-14), 121.81 (C-21), 119.71 (C-19,
23), 118.52 (C-12, 16), 45.99 (C-7), 32.19 (C-8). IR (KBr), ν/cm-1: 3412, 3240, 3036 (NH), 1707, 1652
(CO). MS (ESI, 35V): m/z 419 [M+H]+ (80%). Anal. Calcd for C23H23N5O3: C, 66.17; H, 5.55; N, 16.78.
Found: C. 66.06; H, 5.49; N, 16.55.
3-[Phenyl(phenylthiocarbamoyl)amino]-N-[(phenylthiocarbamoyl)amino]propanamide (8). To a
solution of 2 (4.48 g, 25 mmol) in MeOH (50 mL) phenyl isothiocyanate (10.14 g, 8.97 mL, 75 mmol)
was added dropwise. The reaction mixture was refluxed for 6 h. The crystals were filtered, and
recrystallized from EtOH. Yield 6.5 g (58 %), mp 152–153 ºC. 1H NMR (300 MHz, DMSO-d6): δ 2.65 (t,
2H, J = 8.1 Hz, CH2CO), 4.37 (t, 2H, J = 8.1 Hz, CH2N), 7.25–7.51 (m, 15H, HAr,Ar’,Ar”), 8.86 (s, 1H,
NHAr”), 9.52, 9.58 (2s, 2H, NHNHCS), 9.97 (s, 1H, NHAr’). 13C NMR (75.4 MHz, DMSO-d6): δ 169.95
(C-9), 181.97 (C-17), 180.83 (C-10), 142.95 (C-1), 139.79 (C-11), 139.52 (C-18), 129.50 (C-3, 5), 127.90
(C-2, 6), 128.27 (C-20, 22), 127.78 (C-4), 127.05 (C-13, 15), 121.70 (C-14), 121.79 (C-21), 120.05 (C-19,
23), 119.30 (C-12, 16), 46.21 (C-7), 31.95 (C-8). IR (KBr), ν/cm-1: 3168, 3363 (NH), 1704 (C=O), 1159,
1218 (C=S). MS (ESI, 20V): m/z 450 [M+H]+ (60%). Anal. Calcd for C23H23N5OS2: C, 61.44; H, 5.16; N,
15.58. Found: C, 61.35; H, 5.01; N, 15.13.
4-Phenyl-3-[2-(phenylamino)ethyl]-1H-1,2,4-triazol-5(4H)-one (9). a) A mixture of 5 (0.98 g, 3 mmol)
and 20% KOH aqueous solution (25 mL) was refluxed for 2 h, and cooled down. Then concentrated HCl
was added to pH 4. The crystals were filtered, washed with water, and recrystallized from DMF – water
mixture. Yield 0.57 g (62 %), mp 188–189 ºC. b) A mixture of 7 (1.25 g, 3 mmol) and 20% KOH
aqueous solution (30 mL) was refluxed for 4 h, and cooled down. Acetic acid was added under freezing to
pH 4. The crystals were filtered, washed with water, and recrystallized from DMF – water mixture. Yield
0.59 g (70 %), mp 188–189 ºC. 1H NMR (300 MHz, DMSO-d6): δ 2.63 (t, 2H, J = 7.5 Hz, CH2C), 3.28 (q,
2H, J = 14.7 Hz, NHCH2), 5.67 (t, 1H, J = 6.4 Hz, NHAr), 6.36 (d, 2H, J = 7.5 Hz, Har-2,6), 6.50(t, 1H, J =
7.5 Hz, Har-4), 6.99 (dd, 2H, J = 1.2 Hz, J = 7.5 Hz, Har-3,5), 7.39–7.56 (m, 5H, HAr’), 11.74 (s, 1H, NH).
13C NMR (75.4 MHz, DMSO-d6): δ 154.28 (C-10), 147.93 (C-1), 145.12 (C-9), 132.79 (C-11), 129.34
(C-13, 15); 128.79 (C-3, 5), 128.44 (C-14), 127.50 (C-12, 16), 115.68 (C-4), 111.73 (C-2, 6), 44.51 (C-7),

HETEROCYCLES, Vol. 78, No. 1, 2009
67
33.61 (C-8). IR (KBr), ν/cm-1: 3193, 2920 (NH), 1665 (C=O), 1519, 1367, 1191 (1,2,4-triazole ring),
1157 (N-N). MS (ESI, 20V): 281 [M+H]+ (100%). Anal. Calcd for C16H16N4O: C, 68.55; H, 5.75; N,
19.99. Found: C, 68.28; H, 6.41; N, 19.52.
4-Phenyl-3-[2-(phenylamino)ethyl]-1H-1,2,4-triazole-5(4H)-thione (10). A mixture of 6 (1.57 g, 5
mmol) and 20% KOH aqueous solution (50 mL) was refluxed for 4 h, and cooled down. Concentrated
HCl was added to pH 4. The crystals were filtered, washed with water, and recrystallized from DMF –
o
1
water mixture. Yield 1.61 g (89 %), mp 128–129 C. H NMR (300 MHz, DMSO-d6): δ 2.57 (t, 2H,
CH2C), 3.11 (q, 2H, J = 14.7 Hz, NHCH2), 5.58 (t,1H, J = 6.4 Hz, NHAr), 6.30 (d, 2H, J = 7.5 Hz, Har-2,6),
6.47 (t, 1H, J = 7.3 Hz, Har-4), 6.98 (dd, 2H, J = 7.3, 8.6 Hz, Har-3,5), 7.25 (d, 2H, J=6.9 Hz, HAr-12,16),
7.38–7.48 (m, 3H, HAr-13,14,15), 13.52 (s,1H, NH). 13C NMR (75.4 MHz, DMSO-d6): δ 166.60 (C-10),
148.41 (C-1), 148.16 (C-9), 137.29 (C-11), 128.77 (C-13, 15), 128.47 (C-3, 5), 127.15 (C-12, 15), 115.51
(C-4), 111.175 (C-2, 6), 45.91 (C-7), 33.25 (C-8). IR (KBr), ν/cm-1: 3320; 3392 (NH), 1604, 1497, 1100
(1,2,4-triazole ring), 1101 (CS). MS (ESI, 20V): 297 [M+H]+ (40%). Anal. Calcd for C16H16N4S: C,
64.84; H, 5.44; N, 18.90. Found: C, 64.61; H 5.23; N, 18.70.
N-Phenyl-5-[2-(phenylamino)ethyl]-1,3,4-oxadiazol-2-amine (11). a) A solution of 5 (2.98 g, 0.01 mol)
in POCl3 (20 mL) was refluxed for 36 h. A reaction mixture was poured dropwise on ice. The product was
o
washed with water and crystallized from water. Yield 1.62 g (58 %), mp 157–158 C. b) A mixture of 5
(2.98 g, 0.01 mol) and 15 % HCl solution (20 mL) was refluxed for 1 h, and cooled down to rt. The
reaction mixture was neutralized with Na2CO3. The crystals were filtered, washed with water, and
o
recrystallized from water. Yield 1.80 g (64 %), mp 157–158 C. 1H NMR (300 MHz, DMSO-d6): δ 3.01
(t, 2H, J = 6.75 Hz, CH2CN), 3.44 (t, 2H, J = 6.75 Hz, CH2NH), 3.47 (s, 1H, NHCH2), 6.94 (d, 2H, J =
7.5 Hz, Har-2,6), 6.59 (t, 1H, J = 7.5 Hz, Har-4), 7.11 (d, 2H, J = 7.5 Hz, Har-3,5), 7.30–7.40 (m, 5H, HAr’),
7.42 (s, 1H, NHAr’). IR (KBr), ν/cm-1: 3367; 3366 (NH). MS (ESI, 20V): m/z 281 [M+H]+ (100%). Anal.
Calcd for C16H16N4O: C, 68.55; H, 5.75; N 19,99. Found: C, 68.43; H, 5.71; N, 19.89.
1,3-Diphenyl-3-{2-[5-(phenylamino)-1,3,4-oxadiazol-2-yl]ethyl}urea (12). a) A solution of 7 (2.09 g, 5
mmol) in POCl3 (40 mL) was refluxed for 24 h. The reaction mixture was poured dropwise to an ice –
water mixture. The crystals were filtered, and recrystallized from water. The filtrate was neutralized with
NH4OH; the crystals were filtered, and washed with water. Yield 1.37 g (69 %), mp 160.1–160.7 oC. b) A
mixture of 7 (2.09 g, 5 mmol) and dilute HCl (1:1, 15 mL) was refluxed for 1 h, and cooled down to rt.
The reaction mixture was neutralized with Na2CO3. The crystals were filtered, washed with water, and
o
1
recrystallized from water. Yield 1.05 g (53 %), mp 160.1–160.7 C. H NMR (300 MHz, DMSO-d6): δ
2.61 (t, 2H, J = 7.2 Hz, CH2CN), 3.81 (t, 2H, J = 7.2 Hz, CH2NH), 6.70–6.90 (m, 5H, HAr), 7.08-7.35 (m,
10H, HAr’,Ar”), 7.47, 8.25 (2s, 2H, NHAr, NHAr’). IR (KBr), ν/cm-1: 3285 (NH); 1708 (C=O). MS (ESI,
20V): m/z 400 [M+H]+ (100%). Anal. Calcd for C23H21N5O2: C, 69.16; H, 5.30; N, 17.53. Found: C,

68
HETEROCYCLES, Vol. 78, No. 1, 2009
69.03; H, 5.38; N, 17.51.
N-[2-(5-Oxo-4-phenyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)ethyl]-N-phenylacetamide (13). A solution
of 9 (0.17 g, 0.6 mmol) in acetic anhydride (10 mL) was refluxed for 12 h. The solvent was removed on a
rotary evaporator. The product was crystallized from Et2O, and purified by flash column chromatography
o
1
(acetone:hexane 1:2). Yield 0.13 g (68 %), mp 132–133 C. H NMR (300 MHz, DMSO-d6): δ 1.91 (s,
3H, COCH3), 2.61 (t, 2H, J = 7.2 Hz; CH2CN), 3.64 (t, 2H, J = 7.2 Hz, CH2N), 7.15–7.26 (m, 5H, HAr),
13
7.35–7.47 (m, 5H, HAr’), 11.69 (s, 1H, NH). C NMR (75.4 MHz, DMSO-d6): δ 168.92 (C-17), 154.19
(C-10), 144.41 (C-9), 142.45 (C-1), 132.66 (C-11), 129.52 (C-3, 5), 129.22 (C-14), 128.49 (C-13, 15),
127.20 (C-12, 16), 127.92 (C-4), 127.67 (C-2, 6), 45.32 (C-7), 24.31 (C-8), 22.25 (C-18). IR (KBr),
ν/cm-1: 3188 (NH), 1691 (C=O). MS (ESI, 20V): m/z 222 [M+H]+ (40%). Anal. Calcd for C18H18N4O2: C,
67.07; H 5.63; N, 17.38. Found: C, 66.97; H, 5.70; N, 17.18.
N-Phenyl-5-[2-(phenylamino)ethyl]-1,3,4-thiadiazol-2-amine (14). a) A mixture of 6 (1.57 g, 5 mmol)
and dilute HCl (1:1, 10 mL) was refluxed for 1 h, and cooled down to rt. The reaction mixture was
neutralized with Na2CO3 to pH 4–6. The crystals were filtered, and recrystallized from EtOH. Yield 0.79
o
g (53 %), mp 166–167 C. b) To a concentrated H2SO4 (15 mL) 6 (0.79 g, 2.5 mmol) was added in
portions, and the reaction mixture was stirred at rt for 3 h. Then it was added dropwise to an ice – water
o
mixture. The crystals were filtered, and recrystallized from EtOH. Yield 0.73 g (97 %), mp 166–167 C.
c) A mixture of 5 (1.49 g, 5 mmol), phosphorus pentasulfide (1.33 g, 6 mmol), and xylene (40 mL) was
refluxed for 2 h. The solvent was decanted; the product was crystallized from EtOAc, and washed with
Et2O. Yield 1.01 g (68 %), mp 166–167 oC. 1H NMR (300 MHz, DMSO-d6): δ 3.35 (t, 2H, J = 7.35 Hz,
NCH2CH2), 3.63 (t, 2H, J = 7.35 Hz, NHCH2), 6.98 (dt, 1H, J = 1.05, 7.35 Hz, Har-4), 7.22 (t, 1H, J = 7.05
Hz, Har-14), 7.41 (d, 2H, J = 7.2 Hz, Har-2,6), 7.32 (t, 2H, J = 7.5 Hz, Har-3,5), 7.63 (dd, 2H, J = 1.2, 7.6 Hz,
H
ar-12,16), 7.38 (t, 2H, J = 7.5 Hz, HAr-13,15), 9.98 (br s, 2H, NH). 13C NMR (75.4 MHz, DMSO-d6): δ
164.54 (C-10), 155.65 (C-9), 140.57 (C-1), 139.46 (C-11), 129.58 (C-13, 15), 128.96 (C-3, 5), 121.75
(C-14), 120.12 (C-4), 117.33 (C-12, 16), 111.79 (C-2, 6), 46.91 (C-7), 26.91 (C-8). IR (KBr), ν/cm-1:
3275 (NH); 1604 (CN); 693 (CSC). MS (ESI, 20V): m/z 297 [M+H]+ (70%). Anal. Calcd for C16H16N4S:
C, 64.84; H, 5.44; N, 18.90. Found: C, 64.52; H, 5.28; N, 18.79.
N-Phenyl-N-[2-(4-phenyl-5-sulfanylidene-4,5-dihydro-1H-1,2,4-triazol-3-yl)ethyl]acetamide (15). A
solution of 10 (0.59 g, 2 mmol) in acetic anhydride (25 mL) was refluxed for 6 h. The solvent was
removed on a rotary evaporator. The product was crystallized from EtOH. Yield 0.34 g (68 %), mp.
197–198 oC. 1H NMR (300 MHz, DMSO-d6): δ 1.66 (s, 3H, CH3), 2.65 (t, 2H, J = 6.9 Hz, CH2CN), 3.69
(t, 2H, J = 6.9 Hz, CH2N), 7.18 (d, 2H, J = 6.9 Hz, Har-2,6), 7.33 (t, 1H, J = 6.9 Hz, Har-4), 7.35 (t, 2H, J =
13
6.9 Hz, Har-3,5), 7.39–7.53 (m, 5H, HAr’), 13,76 (s, 1H, NH). C NMR (75.4 MHz, DMSO-d6): δ 167.65
(C-17), 173.22 (C-10), 149.71 (C-9), 143.18 (C-1), 142.26 (C-11), 129.59 (C-3, 5), 127.76 (C-14), 129.41

HETEROCYCLES, Vol. 78, No. 1, 2009
69
(C-13, 15), 127.94 (C-12, 16), 129.27 (C-4), 128.15 (C-2, 6), 45.35 (C-7), 33.44 (C-8), 22.24 (C-18). IR
(KBr), ν/cm-1: 3178 (NH), 1689 (C=O). MS (ESI, 20V): m/z 339 [M+H]+ (30%). Anal. Calcd for
C18H18N4OS: C, 63.88; H, 5.36; N, 16.56. Found: C, 63.79; H 5.28; N 16.47.
Antimicrobial susceptibility tests. Antimicrobial and antifungal activity of new compounds was tested
in vitro in these standard bacterial strains: Staphylococcus aureus ATCC 25923, Enterococcus faecalis
ATCC 29212, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, Klebsiella
pneumoniae ATCC 33495, Proteus mirabilis ATCC 12459, Bacillus subtilis ATCC 6633, and Bacillus
cereus ATCC 8035, and fungal strain Candida albicans ATCC 60193 using a serial agar dilution and
broth dilution method (Mueller-Hinton Agar II and Mueller-Hinton Broth II, BBL, Cockeysville, USA).
Standard cultures of nonsporic bacteria Staphylococcus aureus, Enterococcus faecalis, Escherichia coli,
Pseudomonas aeruginosa, Klebsiella pneumoniae and Proteus mirabilis were cultivated for 20–24 h at
35–37 °C in Mueller-Hinton Agar. A bacterial suspension was prepared from cultivated bacterial cultures
in physiological solution according to turbidity standard 0.5 McFarland (107 CFU/mL).
Standard culture of sporic bacteria Bacillus subtilis and Bacillus cereus was cultivated for 7 days at
35–37 °C in Mueller-Hinton II Agar. After sporic bacteria culture had grown, it was washed away from
the surface of the broth with sterile physiological solution, heated for 30 min at 70 °C and diluted till the
concentration of spores in 1 mL ranged from 10x106 to 100x106.
The standard fungal culture Candida albicans was cultivated for 20–24 h at 30 °C in Mueller-Hinton II
Agar. A fungal suspension was prepared from cultivated fungal cultures in physiological solution
according to the turbidity standard 0.5 McFarland.
After inoculation with a multi-point inoculator delivering 1–2 μl, the final inoculum on the agar surface
should be approximately 104 CFU/spot. For broth dilution MICs the final inoculum should be 105
CFU/mL.
The main solution of the synthesized compounds was prepared in DMSO. Dilutions of 1, 25, 50, 100, 150,
200, 250, 300, 350, 400, 450 and 500 µg/mL were carried out under aseptic conditions by transferring the
necessary amount of the analyzed solution using a sterile pipette to Petri dish filled with 10 mL of
Mueller-Hinton agar and to tubes filled with 2 mL of Mueller-Hinton broth.
The antimicrobial effect of the investigated compounds was determined as Minimum Inhibitory
Concentration (MIC) in µg/mL.15,16 The MIC was defined as the lowest concentration that showed no
growth.
REFERENCES
1. K. Zamani, K. Faghihi, T. Tofighi, and M. R. Shariatzadeh, Turk. J. Chem., 2004, 28, 95.

70
HETEROCYCLES, Vol. 78, No. 1, 2009
2. M. Casic, M. Trkovnik, F. Casic, and E. Has-Schon, Molecules, 2006, 11, 134.
3. I. A. Shehata, Saudi Pharm. J., 2003, 11, No 3, 87.
4. G. Mekuskiene, S. Tumkevicius, and P. Vainilavicius, J. Chem. Res. (S), 2002, 213.
5. A. H. El-Massy, H. H. Fahmy, and S. H. A. Abdelwahed, Molecules, 2000, 5, 1429.
6. M. Wujec, M. Pitucha, M. Dobosz, U. Kosikowska, and A. Malm, Acta Pharm, 2004, 54, 251.
7. K. Beresnevičiūtė, Z. J. Beresnevičius, E. Jakienė, G. Mikulskienė, J. Kihlberg, and J. Broddefalk,
Cheminė technologija, ISSN 1392-1231, 1996, 1, 71.
8. Z.J. Beresnevičius, V. Viliūnas, and K. Kantminienė. Chem. Heterocycl. Comp., 2000, 4, 504.
9. V. Mickevičius, Z. J. Beresnevičius, and E. Jakienė. Biologija, ISSN 1392-0146, 1999, 1, 29.
10. M. Mickevičius, V. Mickevičius, Z. J. Beresnevičius, and E. Jakienė. Cheminė technologija, ISSN
1392-1231, 2005, 3, 50.
11. A. Canisz, M. Koparir, and A. Demirdag, Molecules, 2004, 9, 204.
12. Y. Dündar, B. Çakir, E. Küpeli, M. F. Şahin, and N. Noyanalpan, Turk. J. Chem., 2007, 31, 1.
13. O. Pintilie, L. Profire, V. Sunel, M. Popa, and A. Pui, Molecules, 2007, 12, 103.
14. G. Machtejeva, Ph.D. thesis, Kaunas Polytechnic Institute, Kaunas, Lithuania, 1977.
15. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial
Susceptibility Tests for Bacteria That Grow Aerobically, Approved Standard M7-A7. CLSI: Wayne,
PA, USA, 2006.
16. European Committee on Antimicrobial Susceptibility Testing. Determination of minimum inhibitory
concentrations (MICs) of antibacterial agents by agar dilution. EUCAST Definitive Document E.
Def 3.1. Clinical Microbiology and Infection, 2000, 6, 509.